Parismita Kalita

Parismita Kalita

Auto-generated profile, based on publicly available information

Parismita Kalita

Molecular and Structural Biophysics Laboratory, Department of Biochemistry, North-Eastern Hill University, Shillong 793022, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Microbial Pathogenesis
Verified
Journal Article
Closed access
PKParismita Kalita
Parismita Kalita
APAditya Padhi
Aditya Padhi
KZKam Y. J. Zhang
Kam Y. J. Zhang
Timir TripathiTimir Tripathi
Timir Tripathi

1 May 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
VRVijayakumar Rajendran
Vijayakumar Rajendran
PKParismita Kalita
Parismita Kalita
HSHarish Shukla
Harish Shukla
Awanish KumarAwanish Kumar
Awanish Kumar
Timir TripathiTimir Tripathi
Timir Tripathi

1 October 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
PKParismita Kalita
Parismita Kalita
DLDenzelle Lee Lyngdoh
Denzelle Lee Lyngdoh
APAditya Padhi
Aditya Padhi
HSHarish Shukla
Harish Shukla
Timir TripathiTimir Tripathi
Timir Tripathi

1 January 2015 in MethodsX
Verified
Journal Article
Open access
GCGaurav Chhetri
Gaurav Chhetri
PKParismita Kalita
Parismita Kalita
Timir TripathiTimir Tripathi
Timir Tripathi
Bacterial cells can be engineered to express non-native genes, resulting in the production of, recombinant proteins, which have various biotechnological and pharmaceutical applications. In eukaryotes, such as yeast or mammalian cells, which have large genomes, a higher recombinant protein expression can be troublesome. Comparatively, in the Escherichia coli (E. coli) expression system, although the expression is induced with isopropyl β-d-1-thiogalactopyranoside (IPTG), studies have shown low expression levels of proteins. Irrespective of the purpose of protein production, the production process requires the accomplishment of three individual factors: expression, solubilization and purification. Although several efforts, including changing the host, vector, culture parameters of the recombinant host strain, co-expression of other genes and changing of the gene sequences, have been directed towards enhancing recombinant protein expression, the protein expression is still considered as a significant limiting step. Our protocol explains a simple method to enhance the recombinant protein expression that we have optimized using several unrelated proteins. It works with both T5 and T7 promoters. This protocol can be used to enhance the expressions of most of the proteins. The advantages of this technique are presented below:•It produces several fold increase in the expression of poorly expressed, less expressed or non-expressed recombinant proteins.•It does not employ any additional component such as chaperones, heat shock proteins or co-expression of other genes.•In addition to being inexpensive, easy to manage, universal, and quick to perform, the proposed method does not require any commercial kits and, can be used for various recombinant proteins expressed in the E. coli expression system.

4 July 2017 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
RSRohit Shukla
Rohit Shukla
HSHarish Shukla
Harish Shukla
PKParismita Kalita
Parismita Kalita
ASAmit Sonkar
Amit Sonkar
TPTripti Pandey
Tripti Pandey
Timir TripathiTimir Tripathi
Timir Tripathi
Fasciola gigantica is the causative organism of fascioliasis and is responsible for major economic losses in livestock production globally. F. gigantica thioredoxin1 (FgTrx1) is an important redox-active enzyme involved in maintaining the redox homeostasis in the cell. To identify a potential anti-fasciolid compound, we conducted a structure-based virtual screening of natural compounds from the ZINC database (n = 1,67,740) against the FgTrx1 structure. The ligands were docked against FgTrx1 and 309 ligands were found to have better docking score. These compounds were evaluated for Lipinski and ADMET prediction, and 30 compounds were found to fit well for re-docking studies. After refinement by molecular docking and drug-likeness analysis, three potential inhibitors (ZINC15970091, ZINC9312362, and ZINC9312661) were identified. These three ligands were further subjected to molecular dynamics simulation (MDS) to compare the dynamics and stability of the protein structure after binding of the ligands. The binding free energy analyses were calculated to determine the intermolecular interactions. The results suggested that the two compounds had a binding free energy of –82.237, and –109.52 kJ.mol−1 for compounds with IDs ZINC9312362 and ZINC9312661, respectively. These predicted compounds displayed considerable pharmacological and structural properties to be drug candidates. We concluded that these two compounds could be potential drug candidates to fight against F. gigantica parasites.

26 December 2017 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
RSRohit Shukla
Rohit Shukla
HSHarish Shukla
Harish Shukla
PKParismita Kalita
Parismita Kalita
Timir TripathiTimir Tripathi
Timir Tripathi